Table 1.
Clinical outcome assessment between experimental group (underwent desensitization) and control group (receiving placebo
| Clinical Assessment | Experimental Group (Mean ± SD) | Control Group (Mean ± SD) | P -value |
|---|---|---|---|
| SNOT (0) | 53.95 ± 14.4 | 41.53 ± 9.9 | 0.011 |
| SNOT (1) | 42.74 ± 14.7 | 38.42 ± 9.5 | 0.248 |
| SNOT (6) | 27 ± 10.8 | 39.63 ± 10.5 | 0.001 |
| Lund-MacKay(0) | 14.74 ± 3 | 12.42 ± 1.1 | 0.014 |
| Lund-MacKay(6) | 11.26 ± 2 | 12.05 ± 19 | 0.229 |
| Symptom Score (0) | 15.37 ± 4.8 | 12.42 ± 3.9 | 0.063 |
| Symptom Score (1) | 12.53 ± 4.06 | 11.95 ± 3.5 | 0.49 |
| Symptom Score (6) | 7.95 ± 3.4 | 11.89 ± 4.2 | 0.005 |
| Medication Score (0) | 13.05 ± 1.3 | 11.47 ± 2.2 | 0.021 |
| Medication Score (1) | 12.74 ± 1.5 | 11.58 ± 2.6 | 0.274 |
| Medication Score (6) | 9.47 ± 1.8 | 11.47 ± 2.7 | 0.017 |
(0): at the beginning of the study.
(1): 1 month after initiating the study.
(6): 6 months after initiating the study.